Neuromedin s as novel putative regulator of luteinizing hormone secretion.
Neuromedin S (NMS), a 36 amino acid peptide structurally related to neuromedin U, was recently identified in rat brain as ligand for the G protein-coupled receptor FM4/TGR-1, also termed neuromedin U receptor type-2 (NMU2R). Central expression of NMS appears restricted to the suprachiasmatic nucleus, and NMS has been involved in the regulation of dark-light rhythms and suppression of food intake. Reproduction is known to be tightly regulated by metabolic and photoperiodic cues. Yet the potential contribution of NMS to the control of reproductive axis remains unexplored. We report herein analyses of hypothalamic expression of NMS and NMU2R genes, as well as LH responses to NMS, in different developmental and functional states of the female rat. Expression of NMS and NMU2R genes was detected at the hypothalamus along postnatal development, with significant fluctuations of their relative levels (maximum at prepubertal stage and adulthood). In adult females, hypothalamic expression of NMS (which was confined to suprachiasmatic nucleus) and NMU2R significantly varied during the estrous cycle (maximum at proestrus) and was lowered after ovariectomy and enhanced after progesterone supplementation. Central administration of NMS evoked modest LH secretory responses in pubertal and cyclic females at diestrus, whereas exaggerated LH secretory bursts were elicited by NMS at estrus and after short-term fasting. Conversely, NMS significantly decreased elevated LH concentrations of ovariectomized rats. In summary, we provide herein novel evidence for the ability of NMS to modulate LH secretion in the female rat. Moreover, hypothalamic expression of NMS and NMU2R genes appeared dependent on the functional state of the female reproductive axis. Our data are the first to disclose the potential implication of NMS in the regulation of gonadotropic axis, a function that may contribute to the integration of circadian rhythms, energy balance, and reproduction.
Vigo
E
E
Physiology Section, Department of Cell Biology, Physiology, and Immunology, Faculty of Medicine, University of Córdoba, Avda. Menéndez Pidal s/n, 14004 Córdoba, Spain.
Roa
J
J
López
M
M
Castellano
J M
JM
Fernandez-Fernandez
R
R
Navarro
V M
VM
Pineda
R
R
Aguilar
E
E
Diéguez
C
C
Pinilla
L
L
Tena-Sempere
M
M
D000375:Aging / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D004031:Diestrus / Q000378:metabolism; D004971:Estrus / Q000378:metabolism; D005215:Fasting / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D007031:Hypothalamus / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D010052:Ovariectomy; D011359:Proestrus / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017981:Receptors, Neurotransmitter / Q000235:genetics / Q000378:metabolism*; D012741:Sexual Maturation; D013493:Suprachiasmatic Nucleus / Q000378:metabolism; D014018:Tissue Distribution
D008565:Membrane Proteins; D009479:Neuropeptides; D017981:Receptors, Neurotransmitter; C497950:neuromedin S; C082444:neuromedin U receptor; D011374:Progesterone; D007986:Luteinizing Hormone